Myocardial Regeneration by Reestablishing Tissue Injury Responses in Monkeys of Ischemic Heart Disease
Personal profile:Dr. Y. James Kang currently is a China National One-Thousand-Talents Professor and Director of Regenerative Medicine Research Center at Sichuan University West China Medical College. He also is the President and CEO of Sichuan 3D Bio-printing Institute; the Director of Sichuan Regenerative Medicine Engineering and Technology Center; the Editor-in-Chief of journals Cardiovascular Toxicology and Regenerative Medicine Research; and the Editor of the book series of Methods in Pharmacology and Toxicology. Dr. Kang received Ph.D. in Toxicology and Zoology at Iowa State University in 1989 and completed postdoctoral training in Biochemistry and Molecular Biology at Cornell University Medical Center in 1990. He was Assistant Professor of Pharmacology and Toxicology, University of North Dakota School of Medicine (1991-1996); Associate Professor of Medicine, Pharmacology and Toxicology and University Scholar, University of Louisville School of Medicine (1996-2001); Professor and Distinguished University Scholar (2001-). He served several NIH study sections from 1997 to 2006, and other federal agencies including USDA, US-EPA and US-Veterans Administrations from 1996 to 2005. He was elected to Fellow of the Academy of Toxicological Sciences in 2001. His research interests are in regenerative medicine, focusing on 3D bio-printing and cardiovascular regeneration, as well as dietary manipulation of cardiovascular disease, liver fibrosis and cirrhosis, and non-human primate models of human diseases.
Positions and Affiliations:
China National One-Thousand Talents Professor and Director, Sichuan University Regenerative Medicine Research Center; President and CEO, Sichuan 3D Bio-printing Institute; Director and Chief Scientific Officer, Sichuan Regenerative Medicine Engineering and Technology Center; Professor and Distinguished University Scholar, University of Louisville School of Medicine, Louisville, Kentucky, USA